EUVIMEDEUVIMED entdecken
Crossref

Fingolimod induces cytotoxic stress and apoptosis-like cell death in drug-sensitive and P-glycoprotein-overexpressing acute myeloid leukemia cells

Pavol Štefík, Kamila Ďurišová, Jana Špaldová, Lucia Šofranková, Denisa Nechajová, Albert Breier, Boris Lakatoš

Biochemical and Biophysical Research Communications · 2026-08 · 828 · 154118

DOI: 10.1016/j.bbrc.2026.154118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-08. Verfasst von Pavol Štefík und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, Br…. Hauptthemen laut MEDLINE: Fingolimod Hydrochloride, Apoptosis, Leukemia, Myeloid, Acute, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Slovak Research and Development Agency, Slovak University of Technology in Bratislava, Vedecká Grantová Agentúra MŠVVaŠ SR a SAV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last several years, sphingolipids have been shown to regulate numerous cellular processes, including cell adhesion, migration, proliferation, senescence, death, or differentiation. Dysregulation of sphingolipid metabolism or sphingolipid mediated signaling is usually found in malignant cells, supporting uncontrolled tumor growth, suppression of immune responses, or drug resistance of cancer cells. Hence, novel drugs targeting sphingolipid metabolism or signaling are investigated as promising anticancer agents. Fingolimod is a synthetic analogue of sphingosine and employed for the treatment of relapse-remitting multiple sclerosis. Furthermore, fingolimod has been also studied as a potential antineoplastic drug owing to its ability to modulate metabolism and signaling pathways of cancer cells to promote inhibition of the cell cycle progression or induction of apoptosis. In our work, acute myeloid leukemia cell lines SKM-1 and MOLM-13 were employed together with their sublines displaying a multi-drug resistant phenotype due to P-glycoprotein overexpression. Our results indicate that fingolimod acts as a potent inducer of apoptosis-like cell death with the maximum effect observed after 8 h. This is also accompanied by a decrease in mitochondrial membrane potential, the generation of reactive oxygen species, an increase in intracellular calcium concentration, and the activity of stress-activated kinases JNK and p38. Fingolimod applied in sublethal concentrations can also induce accumulation of cells in the G0/G1 phase; however, this effect is not accompanied by the differentiation of leukemia cells. Although fingolimod treatment led to a decrease in the expression of P-glycoprotein on mRNA level, the same concentration of fingolimod had virtually no effect on its activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fingolimod HydrochlorideApoptosisLeukemia, Myeloid, AcuteATP Binding Cassette Transporter, Subfamily B, Member 1Antineoplastic AgentsHumansCell Line, TumorReactive Oxygen SpeciesDrug Resistance, NeoplasmMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

Acute myeloid leukemiaApoptosis-like cell deathDrug resistanceFingolimodMOLM-13SKM-1

Substanzen

Fingolimod HydrochlorideATP Binding Cassette Transporter, Subfamily B, Member 1Antineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, Bratislava, 812 37, Slovakia. Electronic address: pavol.stefik@stuba.sk.
  • Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, Bratislava, 812 37, Slovakia.
  • Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, Bratislava, 812 37, Slovakia; Centre of Biosciences, Slovak Academy of S…

Förderung

  • Slovak Research and Development Agency
  • Slovak University of Technology in Bratislava
  • Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Zitieren

APA

Štefík, P., Ďurišová, K., Špaldová, J., Šofranková, L., Nechajová, D., Breier, A., & Lakatoš, B. (2026). Fingolimod induces cytotoxic stress and apoptosis-like cell death in drug-sensitive and P-glycoprotein-overexpressing acute myeloid leukemia cells. Biochemical and Biophysical Research Communications, 828, 154118. https://doi.org/10.1016/j.bbrc.2026.154118

Vancouver

Štefík P, Ďurišová K, Špaldová J, Šofranková L, Nechajová D, Breier A, et al. Fingolimod induces cytotoxic stress and apoptosis-like cell death in drug-sensitive and P-glycoprotein-overexpressing acute myeloid leukemia cells. Biochemical and Biophysical Research Communications. 2026;828:154118. doi:10.1016/j.bbrc.2026.154118

BibTeX
@article{tefk2026,
  author = {Štefík, Pavol and Ďurišová, Kamila and Špaldová, Jana and Šofranková, Lucia and Nechajová, Denisa and Breier, Albert and Lakatoš, Boris},
  title = {Fingolimod induces cytotoxic stress and apoptosis-like cell death in drug-sensitive and P-glycoprotein-overexpressing acute myeloid leukemia cells},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {828},
  pages = {154118},
  doi = {10.1016/j.bbrc.2026.154118}
}
Kostenlos starten →